Back to News
Market Impact: 0.3

CVNA Quantitative Stock Analysis

CVNANDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsConsumer Demand & RetailAutomotive & EV
CVNA Quantitative Stock Analysis

Validea's guru fundamental report on Carvana (CVNA) assigned a low 40% rating using Kenneth Fisher's Price/Sales Investor model, which prioritizes low P/S ratios, profit growth, and strong free cash flow. While CVNA passed the price/sales ratio test, it notably failed on critical metrics including total debt/equity, long-term EPS growth, free cash per share, and three-year average net profit margin, indicating significant fundamental weaknesses in profitability and cash flow despite its P/S.

Analysis

According to a Validea fundamental report, Carvana Co. (CVNA) scores a notably low 40% on the Kenneth Fisher Price/Sales Investor model, falling well short of the 80% threshold that would indicate strategic interest. The analysis reveals a significant conflict between the company's valuation and its underlying financial health. While CVNA passes the core criterion of a low price-to-sales ratio, which is central to Fisher's strategy, it fails on several critical fundamental metrics. These weaknesses include a high total debt-to-equity ratio, a lack of long-term EPS growth, negative free cash flow per share, and unsustainable three-year average net profit margins. This profile suggests that despite a potentially attractive valuation based on revenue, the company's financial structure, profitability, and cash generation capabilities are major points of concern.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.50

Ticker Sentiment

CVNA-0.60
NDAQ0.00

Key Decisions for Investors

  • Investors should exercise caution, as the seemingly attractive price-to-sales ratio is significantly undermined by fundamental weaknesses in profitability, cash flow, and balance sheet health.
  • A deep dive into the company's high debt-to-equity ratio is critical to assess balance sheet risk and the company's ability to service its obligations.
  • Given the failures on long-term EPS growth and free cash flow metrics, any investment thesis should be contingent on identifying a clear, near-term catalyst for a turnaround in profitability and cash generation.
  • This analysis suggests the stock may be a value trap; therefore, investors following growth-at-a-reasonable-price (GARP) or value strategies should be particularly wary of the negative fundamental signals.